Citation: | Fuhua Wang, Yunfeng Yang, Xiangyun Guo, Feng Li, Ruihong Yang, Xiaoyu Li, Sutang Guo, Chunyan Wang. Plasma microRNA profiling highlights miR-1260b and miR-720 as novel diagnostic and prognostic biomarkers of esophageal squamous cell carcinoma[J]. Blood&Genomics, 2021, 5(2): 128-134. doi: 10.46701/BG.2021022021115 |
[1] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394−424. doi: 10.3322/caac.21492
|
[2] |
Abnet CC, Arnold M, Wei WQ. Epidemiology of esophageal squamous cell carcinoma[J]. Gastroenterology, 2018, 154(2): 360−373. doi: 10.1053/j.gastro.2017.08.023
|
[3] |
Malhotra GK, Yanala U, Ravipati A, et al. Global trends in esophageal cancer[J]. J Surg Oncol, 2017, 115(5): 564−579. doi: 10.1002/jso.24592
|
[4] |
Wu CC, Li M, Meng HB, et al. Analysis of status and countermeasures of cancer incidence and mortality in China[J]. Sci China Life Sci, 2019, 62(5): 640−647. doi: 10.1007/s11427-018-9461-5
|
[5] |
Cao MM, Li H, Sun DQ, et al. Cancer burden of major cancers in China: a need for sustainable actions[J]. Cancer Commun, 2020, 40(5): 205−210. doi: 10.1002/cac2.12025
|
[6] |
He YT, Li DJ, Liang D, et al. Estimated of esophageal cancer incidence and mortality in China, 2013[J]. Chin J Oncol (in Chinese)
|
[7] |
Liu S, Lin Z, Zheng ZR, et al. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma[J]. Cancer Sci, 2020, 111(10): 3881−3892. doi: 10.1111/cas.14550
|
[8] |
Kawaguchi T, Komatsu S, Ichikawa D, et al. Circulating MicroRNAs: a next-generation clinical biomarker for digestive system cancers[J]. Int J Mol Sci, 2016, 17(9): 1459. doi: 10.3390/ijms17091459
|
[9] |
Wang H, Peng R, Wang J, et al. Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage[J]. Clin Epigenetics, 2018, 10: 59. doi: 10.1186/s13148-018-0492-1
|
[10] |
Carthew RW, Sontheimer EJ. Origins and mechanisms of miRNAs and siRNAs[J]. Cell, 2009, 136(4): 642−655. doi: 10.1016/j.cell.2009.01.035
|
[11] |
Ali Syeda Z, Langden SSS, Munkhzul C, et al. Regulatory mechanism of microRNA expression in cancer[J]. Int J Mol Sci, 2020, 21(5): 1723. doi: 10.3390/ijms21051723
|
[12] |
Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435(7043): 834−838. doi: 10.1038/nature03702
|
[13] |
Hoshino I, Ishige F, Iwatate Y. Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma[J]. Oncol Lett, 2020, 20(6): 350. doi: 10.3892/ol.2020.12213
|
[14] |
Liu C, Tian X, Sun HB, et al. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6[J]. Eur Rev Med Pharmacol Sci, 2019, 23(3): 1069−1076. doi: 10.26355/eurrev_201902_16995
|
[15] |
Shen Y, Ding YJ, Ma Q, et al. Identification of novel circulating miRNA biomarkers for the diagnosis of esophageal squamous cell carcinoma and squamous dysplasia[J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(7): 1212−1220. doi: 10.1158/1055-9965.EPI-18-1199
|
[16] |
Sun HJ, Wang L, Zhao QQ, et al. Diagnostic and prognostic value of serum miRNA-1290 in human esophageal squamous cell carcinoma[J]. Cancer Biomark, 2019, 25(4): 381−387. doi: 10.3233/CBM-190007
|
[17] |
Wang LH, Zhang ZY, Yu XD, et al. SOX9/miR-203a axis drives PI3K/AKT signaling to promote esophageal cancer progression[J]. Cancer Lett, 2020, 468: 14−26. doi: 10.1016/j.canlet.2019.10.004
|
[18] |
Li ML, Meng XL, Li MX. MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy[J]. Aging, 2020, 12(12): 12107−12118. doi: 10.18632/aging.103379
|
[19] |
Lu TX, Rothenberg ME. MicroRNA[J]. J Allergy Clin Immunol, 2018, 141(4): 1202−1207. doi: 10.1016/j.jaci.2017.08.034
|
[20] |
Kabekkodu SP, Shukla V, Varghese VK, et al. Clustered miRNAs and their role in biological functions and diseases[J]. Biol Rev Camb Philos Soc, 2018, 93(4): 1955−1986. doi: 10.1111/brv.12428
|
[21] |
Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects[J]. Mol Diagn Ther, 2016, 20(6): 509−518. doi: 10.1007/s40291-016-0221-4
|
[22] |
Hirata H, Hinoda Y, Shahryari V, Deng G, Tanaka Y, Tabatabai ZL et al. Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells[J]. Br J Cancer, 2014, 110(6): 1645−1654. doi: 10.1038/bjc.2014.48
|
[23] |
Xia Y, Wei K, Hu LQ, et al. Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β-catenin signaling pathway in lung adenocarcinoma[J]. J Cell Physiol, 2020, 235(10): 6843−6853. doi: 10.1002/jcp.29578
|
[24] |
Morita T, Fujiwara T, Yoshida A, et al. Clinical relevance and functional significance of cell-free microRNA-1260b expression profiles in infiltrative myxofibrosarcoma[J]. Sci Rep, 2020, 10(1): 9414. doi: 10.1038/s41598-020-66120-8
|
[25] |
Xu LM, Xu XT, Huang HL, et al. MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK[J]. Pathol Res Pract, 2018, 214(5): 776−783. doi: 10.1016/j.prp.2018.02.002
|
[26] |
Nonaka R, Miyake Y, Hata T, et al. Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer[J]. Int J Oncol, 2015, 47(3): 1097−1102. doi: 10.3892/ijo.2015.3064
|
[27] |
Tang Y, Lin Y, Li C, et al. MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells[J]. Cell Biosci, 2015, 5: 56. doi: 10.1186/s13578-015-0047-5
|
[28] |
Chen P, Zhang GY, Zhou Q, et al. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients[J]. Biosci Rep, 2020, 40(7): BSR20201449. doi: 10.1042/BSR20201449
|
[29] |
Lv ZY, Wang S, Zhao WD, et al. MicroRNA analysis of NCI-60 human cancer cells indicates that miR-720 and miR-887 are potential therapeutic biomarkers for breast cancer[J]. Drug Discov Ther, 2020, 14(4): 197−203. doi: 10.5582/ddt.2020.03058
|
[30] |
Shinozuka E, Miyashita M, Mizuguchi Y, et al. SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells[J]. Biochem Biophys Res Commun, 2013, 430(1): 101−106. doi: 10.1016/j.bbrc.2012.11.005
|